Raymond James & Associates’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,488
Closed -$127K 3919
2022
Q4
$127K Buy
+12,488
New +$127K ﹤0.01% 3550